Among the Glo1 inhibitors, intravenous administration of glycyl, the glutamyl diethyl ether form of S-(N-p-chlorophenyl-N-hydroxycarbamoyl) glutathione (CHG), inhibits melanoma tumor growth. This evidence concerns the gene GLO1 and melanoma.